BioSkryb’s single-cell technology includes industry-first multiomic products, custom assay services, and cutting-edge computational biology. The company’s patented, whole genome amplification method, primary template-directed amplification (PTA), delivers the most complete and accurate coverage of single-cell genomes, and is the differentiated foundation of its ResolveDNA® and ResolveOME™ single-cell core kits. The automatable kits provide sequencing-ready libraries in under 8 hours.
BioSkryb Genomics is transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics. Through its single-cell whole genome and transcriptome amplification tools and custom services, scientists and clinicians gain an unprecedented view of the genome, exome, transcriptome, and proteome within a single cell to better understand mechanisms and management of complex diseases.